Clinical Trials on Post-transplant Lymphoproliferative Disease in Australia
Total 947 results
-
Boehringer IngelheimCompletedLymphoma, FollicularSpain, Belgium, Czechia, France, Croatia, Germany, Austria, New Zealand, Australia, Greece, Hungary, Poland, Russian Federation
-
Hoffmann-La RocheCompleted
-
CelgeneRecruitingLymphoma, B-CellUnited States, Greece, Spain, Australia, Poland, Taiwan, Korea, Republic of
-
Hoffmann-La RocheCompletedPost-Menopausal OsteoporosisSpain, South Africa, Germany, Mexico, Italy, Belgium, United States, Poland, Denmark, Hungary, Czech Republic, France, Norway, United Kingdom, Australia
-
Genentech, Inc.CompletedLymphocytic Leukemia, Chronic, Diffuse Large B-Cell LymphomaUnited States, Australia
-
AmgenCompletedB-cell Precursor Acute Lymphoblastic Leukemia (ALL)Austria, Germany, Italy
-
Arbeitsgemeinschaft medikamentoese TumortherapieMerck Sharp & Dohme LLC; Celgene CorporationTerminatedPeripheral T-Cell Non-Hodgkin's LymphomaAustria
-
Novartis PharmaceuticalsCompletedMultiple MyelomaUnited States, Australia
-
AbbVieGenentech, Inc.; Celgene CorporationWithdrawnMultiple MyelomaUnited States, Australia, Canada, Spain
-
AbbVieCompletedLeukemia | Cancer | T-cell Prolymphocytic Leukemia (T-PLL)United States, Australia, Austria, Finland, France, Germany, Italy, Netherlands, United Kingdom
-
GlaxoSmithKlineRecruitingMultiple MyelomaAustralia, Poland, Taiwan, Korea, Republic of, Japan, United Kingdom, Brazil, Mexico, Turkey, Argentina
-
CephalonCompletedNon-Hodgkin's Lymphoma | Mantle Cell LymphomaAustralia, Canada, United States
-
Smith & Nephew, Inc.Active, not recruitingOsteoarthritis | Rheumatoid Arthritis | Post-traumatic ArthritisUnited States, Sweden, Australia, Canada, Netherlands
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedPost Stroke RecoveryBelgium, Italy, United Kingdom, Korea, Republic of, Czechia, Poland, Brazil, Australia, Hungary, Canada, France, Germany, Netherlands, Spain, Sweden
-
Princess Maxima Center for Pediatric OncologyUniversity of Milano Bicocca; Amgen Europe B.VRecruitingAcute Lymphoblastic Leukemia | Mixed Phenotype Acute LeukemiaNorway, Finland, Denmark, Netherlands, Hungary, Argentina, Australia, Austria, Belgium, Czechia, France, Germany, Ireland, Italy, Japan, Portugal, Saudi Arabia, Sweden
-
Arbeitsgemeinschaft medikamentoese TumortherapieMundipharma Pte Ltd.CompletedLeukemia, Lymphocytic, Chronic, B-CellAustria
-
European Myeloma NetworkJanssen PharmaceuticaRecruitingMultiple MyelomaUnited Kingdom, Czechia, Australia, Austria, Belgium, Denmark, Germany, Greece, Italy, Netherlands, Norway, Serbia, Switzerland, Turkey, Brazil
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Large B-cell LymphomaUnited States, Australia, Canada
-
AstraZenecaTerminatedNon-Hodgkin LymphomaSpain, United States, Korea, Republic of, France, Portugal, Australia, Italy
-
IpsenCompletedPost-stroke Spasticity | Spasticity Post-Traumatic Brain InjuryUnited States, Australia, France, Belgium, Hungary, Poland, Portugal, Slovakia, Czechia, Russian Federation, Italy
-
CelgeneCelgene CorporationCompletedMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States, Australia
-
Arbeitsgemeinschaft medikamentoese TumortherapieRecruiting
-
Medical University of ViennaCompletedPost Other Specified Vaccination EncephalitisAustria
-
Arbeitsgemeinschaft medikamentoese TumortherapieHoffmann-La Roche; LipomedCompletedLymphoma of Mucosa-Associated Lymphoid TissueAustria
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLymphomaUnited States, Australia, Canada
-
Taunton and Somerset HospitalCompleted
-
Hoffmann-La RocheCompletedPostmenopausal OsteoporosisBelgium, Luxembourg, Austria, Greece, Ireland
-
Hoffmann-La RocheRecruitingLymphoma, Non-HodgkinUnited States, Denmark, Italy, France, Australia, United Kingdom
-
AmgenMerck Sharp & Dohme LLCCompletedRelapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)United States, Germany, Spain, Australia, Netherlands, France
-
BeiGeneLymphoma Study AssociationActive, not recruitingClassical Hodgkin LymphomaUnited States, Australia, France, Belgium, Puerto Rico
-
Novartis PharmaceuticalsCompletedPrimary Myelofibrosis | Post-Essential Thrombocythemia Myelofibrosis | Post-Polycythemia Vera-MyelofibrosisBelgium, Italy, Spain, Bulgaria, Turkey, Greece, Russian Federation, Austria, Canada, Japan, Germany
-
Janssen-Cilag Pty LtdCompleted
-
AbbVieGenentech, Inc.Active, not recruitingNon-Hodgkin's Lymphoma | Hematological Malignancies | Chronic Lymphoid Leukemia | CD20-Positive Lymphoid MalignanciesUnited States, Australia
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaSpain, France, United Kingdom, Germany, Australia, Italy
-
AstraZenecaRecruitingLymphoma | Hodgkin Lymphoma | Non-HodgkinKorea, Republic of, United Kingdom, Italy, Germany, France, Spain, United States, Australia
-
AbbVieTerminatedCancer | Multiple Myeloma (MM)United States, Australia, France, Israel, Japan, Spain, Taiwan
-
Apellis Pharmaceuticals, Inc.Active, not recruitingRenal Transplant | C3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative... and other conditionsUnited States, Australia, Austria, United Kingdom, Brazil, Argentina, France, Italy, Netherlands, Spain, Switzerland
-
Therapeutic Advances in Childhood Leukemia ConsortiumEnzon Pharmaceuticals, Inc.TerminatedLymphoblastic Leukemia, Acute, Childhood | Leukemia, Lymphoblastic, Acute | Lymphoblastic Leukemia, Acute | Leukemia, Lymphoblastic, Acute, T CellUnited States, Australia
-
CTI BioPharmaTerminatedPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States, Canada, France, United Kingdom, Australia, Belgium, Germany, New Zealand, Netherlands, Russian Federation, Hungary, Czechia
-
Novartis PharmaceuticalsCompletedLymphoma | Leukemia | Multiple MyelomaUnited States, Germany, Australia
-
Novartis PharmaceuticalsCompletedRelapsed or Refractory Multiple MyelomaGermany, Spain, Singapore, United States, Australia
-
Syndax PharmaceuticalsActive, not recruitingChronic Graft-versus-host-diseaseKorea, Republic of, United States, Spain, Taiwan, France, Singapore, Belgium, Germany, Italy, Canada, Israel, Australia, United Kingdom, Greece, Poland, Portugal
-
CelgeneActive, not recruitingMultiple MyelomaAustria
-
Austrian Forum Against CancerCompletedMultiple MyelomaAustria, Czech Republic
-
Constellation PharmaceuticalsActive, not recruitingPrimary Myelofibrosis | Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisKorea, Republic of, Spain, United States, Canada, Taiwan, Czechia, United Kingdom, Australia, Italy, Belgium, Germany, France, Israel, Greece, Malaysia, Netherlands, Austria, Turkey, Poland, Thailand, Hong Kong, Hungary
-
Gilead SciencesThe Leukemia and Lymphoma SocietyActive, not recruitingNon Hodgkin LymphomaUnited States, Australia, United Kingdom
-
BeiGeneCompletedWaldenström's MacroglobulinemiaUnited States, Spain, Australia, France, United Kingdom, Germany, Netherlands, Czechia, Italy, Poland, Belgium, Greece, Sweden
-
Novartis PharmaceuticalsCompletedRelapsed and Refractory Multiple MyelomaItaly, Germany, Singapore, Australia, United States
-
AbbVieGenentech, Inc.CompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Australia
-
Hoffmann-La RocheTerminatedLymphoma, Large B-Cell, Diffuse | Follicular LymphomaUnited States, Australia, Germany, Korea, Republic of, New Zealand